Paradigm Biocapital Advisors LP
- SEC CIK
- 0001855655
- Latest filing
- Aug 14, 2026
URGN holding history
UroGen Pharma Ltd. in every 13F filed by Paradigm Biocapital Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
URGN overviewAll 13F holders of URGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q3 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −1,703,949−100.0% | Sold out | Holders |
| Q1 2026 | 1,703,949 | $30.6M | 0.6% | −2,769,699−61.9% | Reduced | Holders |
| Q4 2025 | 4,473,648 | $104.8M | 2.8% | +257,564+6.1% | Added | Holders |
| Q3 2025 | 4,216,084 | $84.1M | 2.5% | +4,216,084 | New | Holders |